GSK enters agreement to acquire IDRx, Inc.

2 days ago · Under the terms of the agreement, GSK will acquire one hundred percent (100%) of the outstanding equity interests (including all options and other incentive equity) in IDRx for up …

100%
OFF

GSK Enters Agreement To Acquire IDRx, Inc.

2 weeks from now

2 days ago · Under the terms of the agreement, GSK will acquire one hundred percent (100%) of the outstanding equity interests (including all options and other incentive equity) in IDRx for up …

gsk.com

$1
OFF

IDRx To Be Acquired By GSK For $1 Billion Upfront, And Additional …

2 weeks from now

2 days ago · The Public M&A and Life Sciences teams advised IDRx, Inc. on its agreement to be acquired by GSK plc (LSE/NYSE: GSK) for $1 billion upfront, with potential for an additional …

goodwinlaw.com

$1
OFF

JPM25: M&A Strategist GSK Acquires IDRX For $1B Upfront

2 weeks from now

2 days ago · GSK is doling out $1 billion in cash for the Boston-based biotech, tacking on the potential for an additional $150 million regulatory approval milestone payment, according to a …

fiercebiotech.com

100%
OFF

GSK Enters Agreement To Acquire IDRx, Inc. - Financial Times

2 weeks from now

2 days ago · Under the terms of the agreement, GSK will acquire one hundred percent (100%) of the outstanding equity interests (including all options and other incentive equity) in IDRx for up …

ft.com

100%
OFF

GSK Enters Agreement To Acquire IDRx, Inc. - BioSpace

2 weeks from now

2 days ago · Under the terms of the agreement, GSK will acquire one hundred percent (100%) of the outstanding equity interests (including all options and other incentive equity) in IDRx for up …

biospace.com

$1
OFF

GSK Enters Agreement To Acquire IDRx, Inc. - Yahoo Finance

2 weeks from now

2 days ago · Under the agreement, GSK will pay $1 billion upfront, with potential for an additional $150 million success-based regulatory approval milestone payment. The acquisition includes …

yahoo.com

$1.15
OFF

GSK To Acquire IDRx For $1.15bn — Financier Worldwide

2 weeks from now

1 day ago · Drug manufacturer GSK has agreed to acquire US biopharmaceutical firm IDRx, which is developing a therapy for the treatment of gastrointestinal stromal tumours (GIST). …

financierworldwide.com

$1.15
OFF

GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion

2 weeks from now

2 days ago · British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a rare type of …

reuters.com

$1
OFF

GSK Boosts Cancer Drug Pipeline With $1B Acquisition Of IDRx

2 weeks from now

2 days ago · The acquisition, valued at up to $1.15 billion, includes an upfront payment of $1 billion and the potential for an additional $150 million contingent on regulatory success. IDRx …

indiatimes.com

53%
OFF

GSK To Buy US-Based Stomach Cancer Drug Developer For Over …

2 weeks from now

2 days ago · GSK acquires IDRx for $1 billion upfront, with $150M milestone payments; gains lead molecule IDRX-42 for gastrointestinal stromal tumors. IDRX-42 shows 53% ORR in 1 …

benzinga.com

$1.15
OFF

GSK To Buy Boston-based IDRx For $1.15 Billion - MSN

2 weeks from now

Under the agreement signed by both companies, GSK will pay $1 billion upfront, with the potential for an additional $150 million success-based regulatory approval milestone payment.The …

msn.com

$1.15
OFF

JP Morgan 2025: GSK Acquires IDRx In $1.15bn Deal - Yahoo Finance

2 weeks from now

2 days ago · JP Morgan 2025: GSK acquires IDRx in $1.15bn deal. The deal includes an upfront payment of $1bn and an additional $150m tied to regulatory milestones. Credit: Bloomberg via …

yahoo.com

$1.15
OFF

British Pharma Giant GSK To Acquire U.S. Drug Developer IDRx In …

2 weeks from now

1 day ago · British pharma giant GSK to acquire U.S. drug developer IDRx in $1.15 billion deal. BY AFP. Emma Walmsley, chief executive officer of GlaxoSmithKline (GSK). LEONARDO …

fortune.com

$1.15
OFF

GSK To Acquire IDRx In $1.15B Deal | Precision Medicine Online

2 weeks from now

2 days ago · Under the agreement, GSK will pay $1 billion upfront and may pay an additional $150 million if IDRx meets certain regulatory approval milestones. GSK will acquire all …

precisionmedicineonline.com

100%
OFF

GSK Enters Agreement To Acquire IDRx, Inc. – IDRx

2 weeks from now

2 days ago · Under the terms of the agreement, GSK will acquire one hundred percent (100%) of the outstanding equity interests (including all options and other incentive equity) in IDRx for up …

idrx.com

$1.15
OFF

GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion

2 weeks from now

2 days ago · British drugmaker GSK agrees to acquire Boston-based biopharmaceutical firm IDRx for up to $1.15 billion, with an initial $1 billion payment. IDRx develops a treatment for …

indiatimes.com

100%
OFF

GSK Acquires IDRx For $1B, Gaining Breakthrough GIST Cancer …

2 weeks from now

2 days ago · Under the terms of the agreement, GSK will acquire one hundred percent (100%) of the outstanding equity interests (including all options and other incentive equity) in IDRx for up …

stocktitan.net

$1.15
OFF

GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion - U.S. News

2 weeks from now

2 days ago · (Reuters) -British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a …

usnews.com

100%
OFF

GSK Enters Agreement To Acquire IDRx, Inc. | Morningstar

2 weeks from now

2 days ago · Under the terms of the agreement, GSK will acquire one hundred percent (100%) of the outstanding equity interests (including all options and other incentive equity) in IDRx for up …

morningstar.com

$1.15
OFF

GSK To Buy Precision Therapeutics Firm IDRx For Up To USD1.15 Billion

2 weeks from now

2 days ago · GSK to buy IDRx for up to $1.15bn (Sharecast News) - GSK on Monday said it was buying US-based biopharmaceutical company IDRx for up to $1.15bn. 10 Jan 2025 08:58

lse.co.uk

100%
OFF

GSK Enters Agreement To Acquire IDRx, Inc. - Lelezard.com

2 weeks from now

2 days ago · Under the terms of the agreement, GSK will acquire one hundred percent (100%) of the outstanding equity interests (including all options and other incentive equity) in IDRx for up …

lelezard.com

$1.15
OFF

GSK Acquiring US-Based IDRx For Up To $1.15 Billion - MSN

2 weeks from now

GSK (GSK) has agreed to acquire Boston-based IDRx for up to $1.15 billion as the British drugmaker looks to expand its gastrointestinal cancer portfolio, the companies said Monday. …

msn.com

$1.15
OFF

GSK To Acquire GIST Drug Developer IDRx For Up To $1.15 Bln Cash

2 weeks from now

2 days ago · (RTTNews) - British drug maker GSK plc (GSK.L, GSK) Monday announced that it has signed an agreement to acquire IDRx, a Boston-based, clinical-stage biopharmaceutical …

businessinsider.com

$1
OFF

GSK To Acquire IDRx For $1B Upfront - Markets Insider

2 weeks from now

2 days ago · Under the terms of the agreement, GSK will acquire one hundred percent of the outstanding equity interests in IDRx for up to $1.15B of total cash consideration, comprising an …

businessinsider.com

$1.15
OFF

GSK Up To $1.15 Billion Acquisition Of IDRx | Davis Polk

2 weeks from now

Davis Polk is advising GSK plc on its acquisition of IDRx, Inc., including lead molecule IDRX-42, for up to $1.15 billion of total cash consideration, comprising an upfront payment of $1 billion …

davispolk.com

$1
OFF

GSK Acquires IDRx For $1 Billion To Advance Precision Therapy For …

2 weeks from now

1 day ago · GSK plc has announced the acquisition of IDRx, Inc., a Boston-based clinical-stage biopharmaceutical company developing precision therapeutics for gastrointestinal stromal …

nextedge.in

$1
OFF

GSK To Acquire Biopharma Firm IDRx For $1B And Earnout Of Up …

2 weeks from now

2 days ago · GSK plc (NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based, clinical-stage …

sahmcapital.com

FAQs about GSK enters agreement to acquire IDRx, Inc. Coupon?

How much money will GSK invest in idrx?

Under the terms of the agreement, GSK will acquire one hundred percent of the outstanding equity interests in IDRx for up to $1.15B of total cash consideration, comprising an upfront payment of $1B with potential for an additional $150M success-based regulatory approval milestone payment. ...

How much will GSK pay for idrx-42?

Under the agreement, GSK will pay $1 billion upfront, with potential for an additional $150 million success-based regulatory approval milestone payment. The acquisition includes lead molecule, IDRX-42, a highly selective KIT TKI being developed as a first- and second-line therapy for the treatment of GIST. ...

Is GSK acquiring idrx?

(RTTNews) - British drug maker GSK plc (GSK.L, GSK) Monday announced that it has signed an agreement to acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company, for up to $1.15 billion in cash. ...

Why did GSK acquire idrx-42?

“IDRX-42 complements our growing portfolio in gastrointestinal cancers. This acquisition is consistent with our approach of acquiring assets that address validated targets and where there is clear unmet medical need, despite existing approved products.” said Luke Miels, Chief Commercial Officer, GSK. ...

How much will GSK pay upfront?

Under the agreement signed by both companies, GSK (GSK) will pay $1 billion upfront, with the potential for an additional $150 million success-based regulatory approval milestone payment. Th... ...

Who owns idrx?

IDRx counts Andreessen Horowitz, Casdin Capital, Nextech Invest, Forge Life Science Partners, and RA Capital Management among its investors. GSK (GSK) has agreed to acquire Boston-based IDRx for up to $1.15 billion as the British drugmaker looks to expand its gastrointestinal cancer portfolio, the companies said Monday. ...